查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402923

鼻咽癌治療市場（治療類型：放射治療、化療、免疫治療等；最終用戶：醫院、專科診所等）- 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031

Nasopharyngeal Cancer Treatment Market (Treatment Type: Radiation Therapy, Chemotherapy, Immunotherapy, and Others; End-user: Hospitals, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 203 Pages | 商品交期: 2-10個工作天內

價格

鼻咽癌治療市場 - 報告範圍

TMR 關於全球鼻咽癌治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球鼻咽癌治療的收入2017- 2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球鼻咽癌治療市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解鼻咽癌治療市場。

市場概況
2023年市場價值 5.743 億美元
2031 年市場價值 11 億美元
CAGR 7.3%

該報告深入探討了全球鼻咽癌治療市場的競爭格局。全球鼻咽癌治療市場的主要參與者已經確定，並且每位參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球鼻咽癌治療市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2023-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 疾病流行病學
  • 管道分析
  • 核准治療鼻咽癌的藥物清單
  • 重要產業活動（產品發布/合併、收購和合作夥伴關係）
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依治療類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值與銷售預測：按治療類型，2023-2031
    • 放射治療
    • 化療
    • 免疫療法
    • 其他
  • 市場吸引力分析：按治療類型

第 7 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2023-2031
    • 醫院
    • 專科診所
    • 其他
  • 市場吸引力分析：按最終用戶

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 9 章：北美市場分析與預測

第 10 章：歐洲市場分析與預測

第 11 章：亞太市場分析與預測

第 12 章：拉丁美洲市場分析與預測

第 13 章：中東和非洲市場分析與預測

第14章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Biocon Limited
    • BeiGene Ltd.
    • Shanghai Junshi Biosciences Co., Ltd.
    • Innogene Kalbiotech
    • Center of Molecular Immunology
    • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    • Bristol-Myers Squibb Company
    • Merck & Co., Inc.
    • Biosyngen Pte. Ltd.
Product Code: TMRGL78176

Nasopharyngeal Cancer Treatment Market - Scope of Report

TMR's report on the global nasopharyngeal cancer treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal cancer treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal cancer treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal cancer treatment market.

Market Snapshot
Market Value in 2023US$ 574.3 Mn
Market Value in 2031US$ 1.1 Bn
CAGR7.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal cancer treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal cancer treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal cancer treatment market.

The report delves into the competitive landscape of the global nasopharyngeal cancer treatment market. Key players operating in the global nasopharyngeal cancer treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal cancer treatment market profiled in this report.

Key Questions Answered in Global nasopharyngeal cancer treatment Market Report:

  • What is the sales/revenue generated by nasopharyngeal cancer treatment across all regions during the forecast period?
  • What are the opportunities in the global nasopharyngeal cancer treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nasopharyngeal Cancer Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global nasopharyngeal cancer treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nasopharyngeal cancer treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal cancer treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasopharyngeal Cancer Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Disease Epidemiology
  • 5.2. Pipeline Analysis
  • 5.3. List of Drugs Approved for Nasopharyngeal Cancer
  • 5.4. Key Industry Events (product launches/mergers, acquisitions & partnerships)
  • 5.5. COVID-19 Pandemic Impact on Industry

6. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 6.3.1. Radiation therapy
    • 6.3.2. Chemotherapy
    • 6.3.3. Immunotherapy
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2023-2031
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Nasopharyngeal Cancer Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Nasopharyngeal Cancer Treatment Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 9.2.1. Radiation therapy
    • 9.2.2. Chemotherapy
    • 9.2.3. Immunotherapy
    • 9.2.4. Others
  • 9.3. Market Value Forecast, by End-user, 2023-2031
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2023-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Treatment Type
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Nasopharyngeal Cancer Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 10.2.1. Radiation therapy
    • 10.2.2. Chemotherapy
    • 10.2.3. Immunotherapy
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by End-user, 2023-2031
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Treatment Type
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Nasopharyngeal Cancer Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 11.2.1. Radiation therapy
    • 11.2.2. Chemotherapy
    • 11.2.3. Immunotherapy
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by End-user, 2023-2031
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Clinics
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Treatment Type
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Nasopharyngeal Cancer Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 12.2.1. Radiation therapy
    • 12.2.2. Chemotherapy
    • 12.2.3. Immunotherapy
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by End-user, 2023-2031
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Clinics
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Treatment Type
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Nasopharyngeal Cancer Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value & Volume Forecast, by Treatment Type, 2023-2031
    • 13.2.1. Radiation therapy
    • 13.2.2. Chemotherapy
    • 13.2.3. Immunotherapy
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by End-user, 2023-2031
    • 13.3.1. Hospitals
    • 13.3.2. Specialty Clinics
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of MEA
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Treatment Type
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Biocon Limited
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. BeiGene Ltd.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Shanghai Junshi Biosciences Co., Ltd.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Innogene Kalbiotech
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Center of Molecular Immunology
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Bristol-Myers Squibb Company
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Merck & Co., Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Biosyngen Pte. Ltd.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 02: Global Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 03: Global Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 04: North America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 05: North America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 06: North America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 07: Europe Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 08: Europe Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 09: Europe Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Asia Pacific Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 11: Asia Pacific Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 12: Asia Pacific Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 13: Latin America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 14: Latin America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 15: Latin America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 16: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031
  • Table 17: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 18: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

List of Figures

  • Figure 01: Global Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 03: Global Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 04: Global Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 05: Global Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 06: Global Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 07: Global Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 08: North America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 09: North America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 10: North America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 11: North America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 12: North America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 13: North America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14: North America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 15: Europe Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 16: Europe Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 17: Europe Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 18: Europe Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Europe Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 20: Europe Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 21: Europe Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 22: Asia Pacific Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 23: Asia Pacific Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 24: Asia Pacific Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 25: Asia Pacific Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Asia Pacific Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Asia Pacific Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28: Asia Pacific Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 29: Latin America Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 30: Latin America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 31: Latin America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 32: Latin America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Latin America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 34: Latin America Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 35: Latin America Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 37: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
  • Figure 38: Middle East & Africa Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
  • Figure 39: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Middle East & Africa Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 41: Middle East & Africa Nasopharyngeal Cancer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Middle East & Africa Nasopharyngeal Cancer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Global Nasopharyngeal Cancer Treatment Market Share Analysis, by Company, 2022